The draft version of the medical guideline on the diagnosis and treatment of Aspergillus disease has now entered into the public consultation phase. The guideline is a result of the concerted efforts of ESCMID, through its fungal infections study group (EFISG), the European Confederation of Medical Mycology (ECMM) and the European Respiratory Society (ERS).
Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback. We are happy to receive your feedback and comments on the manuscript until 09 May 2017. Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.